A growing disparity in diabetes-related mortality U.S. trends, 1989-2005.
A growing disparity in diabetes-related mortality U.S. trends, 1989-2005.
复制标题
DOI:
10.1016/j.amepre.2008.09.041
复制
发表时间:
2009-02
影响因子:
5.5
通讯作者:
Hamman RF
中科院分区:
文献类型:
--
作者:
Miech RA;Kim J;McConnell C;Hamman RF
Whether a disparity in diabetes-related death across education levels has widened, narrowed, or remained constant over the past 15 years is not known, and is the topic of this study. The analysis also examined concomitant trends by education levels in possible mechanisms that link education and diabetes-related mortality. The first part of the analysis calculates diabetes-related mortality rates for adults age 40-64 and adults age 65-79 using U.S. Vital Statistics from 1989-2005 to provide the number of deaths per year in the U.S. (the numerator) and also from the U.S. Census to provide the population size (the denominator). The second part of the analysis uses the U.S. National Health and Nutrition Examination Surveys (NHANES) program in 1988-1994 and 1999-2004 to examine trends in diabetes prevalence and diabetes-related factors. A disparity in diabetes-related mortality across education levels widened substantially from the late 1980s to the present, an overall trend apparent in the subgroups of men, women, Blacks, Whites, and Hispanics. Analysis of NHANES data indicated that progress in diabetes care and management (as indicated by HbA1c levels less than 8%) has helped people of all educational levels but has been of greater benefit to those with higher education. The widening disparity across education levels in diabetes-related mortality follows a classic, “early adoption” pattern. Societal advances in diabetes care and self-management – particularly in glucose control -- have benefited people in all social strata, but the pace of improvement has been quicker for people with higher educational attainment. Developing policies and interventions to speed up the pace among people with lower education represents a promising approach to reduce diabetes-related mortality further.